In reigniting the Cancer Moonshot initiative, President Biden called on the biopharmaceutical industry to develop new treatments, make drugs more affordable, and share knowledge. But while the program launched in 2016 had specific goals to increase research, the reboot is primarily targeting cancer screening.
At a 2 February briefing in the White House East Room, Biden said the goal was to “supercharge the Cancer Moonshot” to cut the death rate from cancer by 50% over the next 25 years and provide a more supportive environment for
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?